Evidence map›Paper›PMID 33077298›Full record

ArticleVaccine2020

Assessment of missed opportunities for vaccination (MOV) in Burkina Faso using the World Health Organization's revised MOV strategy: Findings and strategic considerations to improve routine childhood immunization coverage.

Lassané Kaboré, Bertrand Meda, Isaie Médah, Stephanie Shendale, Laura Nic Lochlainn, Colin Sanderson, Mâ Ouattara, William M F Kaboré, Edouard Betsem, Ikechukwu U Ogbuanu

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. [Determinants of vaccine acceptance in Makokou, Gabon].The Pan African medical journal · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Lassané KaboréAgence de Médecine Préventive (AMP), Ouagadougou, Burkina Faso. Electronic address: lassane.kabore1@yahoo.fr.
Bertrand MedaAgence de Médecine Préventive (AMP), Ouagadougou, Burkina Faso.
Isaie MédahMinistry of Health, Direction de la Prévention par les Vaccinations (DPV), Ouagadougou, Burkina Faso.
Stephanie ShendaleDepartment of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland.
Laura Nic LochlainnDepartment of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland.
Colin SandersonLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
Mâ OuattaraWorld Health Organization, Country Office, Ouagadougou, Burkina Faso.
William M F KaboréMinistry of Health, Direction de la Prévention par les Vaccinations (DPV), Ouagadougou, Burkina Faso.
Edouard BetsemAgence de Médecine Préventive (AMP), Ouagadougou, Burkina Faso; Laboratoire Mixte International de Vaccinologie (LAMIVAC), Bobo-Dioulasso, Burkina Faso.
Ikechukwu U OgbuanuDepartment of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland.
World Health Organization · CHAgence de Médecine Préventive · FRDirection Générale de la Pharmacie, du Médicament et des Laboratoires · BFLondon School of Hygiene & Tropical Medicine · GBWest African Health Organisation · BF

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundDespite the remarkable achievements of the Expanded Programme on Immunization (EPI) in Burkina Faso, numerous challenges remain, including missed opportunities for vaccination (MOV) which occur when people visit a health facility with at least one vaccine due according to the national immunization schedule, are free of contraindications, and leave without receiving all due vaccine doses. In 2016, we used the revised World Health Organization's (WHO) MOV strategy to assess the extent of and reasons for MOV in Burkina Faso.

methodsWe purposively selected 27 primary health facilities (PHFs) from the eight health districts with the highest absolute numbers of children who missed the first dose of measles-rubella (MR1) in 2015. We conducted exit interviews with caregivers of children aged 0-23 months, and requested health workers to complete a self-administered knowledge, attitudes and practices (KAP) questionnaire.

resultsA total of 489 caregivers were interviewed, of which 411 were eligible for inclusion in our analysis. Medical consultation (35%) and vaccination (24.5%) were the most frequent reasons for visiting PHFs. Among the 73% of children eligible for vaccination, 76% of vaccination opportunities were missed. Among eligible children, the percentage with MOV was significantly higher in those aged ≥12 months and also in those attending for a reason other than vaccination. A total of 248 health workers completed the KAP questionnaire. Of these, 70% (n = 168/239) considered their knowledge on immunization to be insufficient or outdated; 83% failed to correctly identify valid contraindications to vaccination.

conclusionAddressing MOV offers the potential for substantial increases in vaccine coverage and equity, and ultimately reducing the burden of vaccine-preventable diseases (VPDs). This will require the implementation of a series of interventions aimed at improving community knowledge and practices, raising health workers' awareness, and fostering the integration of immunization with other health services.

Indexed as

Immunization ProgramsVaccinationVaccination CoverageWorld Health OrganizationBurkina FasoChildChild, PreschoolHumansImmunization ScheduleInfantInfant, NewbornBurkina FasoMissed opportunitiesReduction strategyRoutine EPIVaccinationVaccine

Identifiers

PMID33077298
PMCPMC7604568
OpenAlexW3093009085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.